201 related articles for article (PubMed ID: 34392602)
1. Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010-2020).
Camerino M; Giacobino D; Manassero L; Iussich S; Riccardo F; Cavallo F; Tarone L; Olimpo M; Lardone E; Martano M; Del Magno S; Buracco P; Morello E
Vet Comp Oncol; 2022 Mar; 20(1):189-197. PubMed ID: 34392602
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prognostic impact of pre-treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4-antigen electrovaccination: an explorative study.
Camerino M; Giacobino D; Iussich S; Ala U; Riccardo F; Cavallo F; Martano M; Morello E; Buracco P
Vet Comp Oncol; 2021 Jun; 19(2):353-361. PubMed ID: 33443307
[TBL] [Abstract][Full Text] [Related]
3. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
Giacobino D; Camerino M; Riccardo F; Cavallo F; Tarone L; Martano M; Dentini A; Iussich S; Lardone E; Franci P; Valazza A; Manassero L; Del Magno S; De Maria R; Morello E; Buracco P
Vet Comp Oncol; 2021 Dec; 19(4):651-660. PubMed ID: 33751759
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.
Piras LA; Riccardo F; Iussich S; Maniscalco L; Gattino F; Martano M; Morello E; Lorda Mayayo S; Rolih V; Garavaglia F; De Maria R; Lardone E; Collivignarelli F; Mignacca D; Giacobino D; Ferrone S; Cavallo F; Buracco P
Vet Comp Oncol; 2017 Sep; 15(3):996-1013. PubMed ID: 27146852
[TBL] [Abstract][Full Text] [Related]
5. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.
Verganti S; Berlato D; Blackwood L; Amores-Fuster I; Polton GA; Elders R; Doyle R; Taylor A; Murphy S
J Small Anim Pract; 2017 Jan; 58(1):10-16. PubMed ID: 28094857
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
Brockley LK; Cooper MA; Bennett PF
N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
[TBL] [Abstract][Full Text] [Related]
7. [Developmental studies on melanoma of the skin and mouth mucosa of dogs].
Frese K
Vet Pathol; 1978 Jul; 15(4):461-73. PubMed ID: 695220
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
Boston SE; Lu X; Culp WT; Montinaro V; Romanelli G; Dudley RM; Liptak JM; Mestrinho LA; Buracco P
J Am Vet Med Assoc; 2014 Aug; 245(4):401-7. PubMed ID: 25075823
[TBL] [Abstract][Full Text] [Related]
9. Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial.
Riccardo F; Tarone L; Camerino M; Giacobino D; Iussich S; Barutello G; Arigoni M; Conti L; Bolli E; Quaglino E; Merighi IF; Morello E; Dentini A; Ferrone S; Buracco P; Cavallo F
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580930
[TBL] [Abstract][Full Text] [Related]
10. CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA.
Riccardo F; Iussich S; Maniscalco L; Lorda Mayayo S; La Rosa G; Arigoni M; De Maria R; Gattino F; Lanzardo S; Lardone E; Martano M; Morello E; Prestigio S; Fiore A; Quaglino E; Zabarino S; Ferrone S; Buracco P; Cavallo F
Clin Cancer Res; 2014 Jul; 20(14):3753-62. PubMed ID: 24874834
[TBL] [Abstract][Full Text] [Related]
11. Prognosis after surgical excision of canine melanomas.
Bostock DE
Vet Pathol; 1979 Jan; 16(1):32-40. PubMed ID: 462717
[TBL] [Abstract][Full Text] [Related]
12. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
[TBL] [Abstract][Full Text] [Related]
13. Electrochemotherapy in treatment of canine oral malignant melanoma and factors influencing treatment outcome.
Tellado MN; Maglietti FH; Michinski SD; Marshall GR; Signori E
Radiol Oncol; 2020 Mar; 54(1):68-78. PubMed ID: 32187017
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of chemotherapeutic effect without wide-margin surgery or radiation therapy in dogs with oral malignant melanoma.
Xia Y; Liao AT; Lee J
Can Vet J; 2024 Apr; 65(4):343-350. PubMed ID: 38562982
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of somatic focal amplifications on chromosome 30 in canine oral melanoma.
Prouteau A; Chocteau F; de Brito C; Cadieu E; Primot A; Botherel N; Degorce F; Cornevin L; Lagadic MA; Cabillic F; de Fornel-Thibaud P; Devauchelle P; Derrien T; Abadie J; André C; Hédan B
Vet Comp Oncol; 2020 Jun; 18(2):214-223. PubMed ID: 31461207
[TBL] [Abstract][Full Text] [Related]
16. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional retrospective study of canine foot pad malignant melanomas: 20 cases.
Jeon MD; Leeper HJ; Cook MR; McMillan SK; Bennett T; Murray CA; Tripp CD; Curran KM
Vet Comp Oncol; 2022 Dec; 20(4):854-861. PubMed ID: 35771690
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma.
Treggiari E; Grant JP; North SM
J Vet Med Sci; 2016 Jun; 78(5):845-50. PubMed ID: 26781703
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma.
Ottnod JM; Smedley RC; Walshaw R; Hauptman JG; Kiupel M; Obradovich JE
Vet Comp Oncol; 2013 Sep; 11(3):219-29. PubMed ID: 23909996
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma.
Guillén A; Stiborova K; Ressel L; Blackwood L; Finotello R; Amores-Fuster I; Jama N; Killick D
Res Vet Sci; 2021 Jul; 137():226-234. PubMed ID: 34023546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]